Intelligent Bio Solutions Inc.
INBS
$2.47
$0.041.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.62% | -13.16% | -5.58% | -4.31% | -4.06% |
| Total Depreciation and Amortization | -3.63% | -1.61% | -3.55% | -0.04% | -0.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.71% | 242.93% | 100.62% | 402.31% | 446.49% |
| Change in Net Operating Assets | -69.94% | 20.09% | 95.73% | 23.11% | -2.71% |
| Cash from Operations | -23.25% | -5.22% | 7.16% | 4.79% | -1.11% |
| Capital Expenditure | 45.77% | -75.34% | -108.24% | -36.50% | -4.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 63.07% | -54.30% | -85.14% | -36.50% | -4.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 225.89% | 281.74% | -41.29% | -44.44% | -68.42% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 225.89% | 281.74% | -28.76% | -44.44% | -68.42% |
| Foreign Exchange rate Adjustments | -94.49% | 189.52% | 187.37% | -105.26% | 4,633.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 156.25% | 161.53% | -233.71% | -161.25% | -210.85% |